Aldose reductase expression in human diabetic retina and retinal pigment epithelium

S. A. Vinores, Peter A Campochiaro, E. H. Williams, E. E. May, W. R. Green, R. L. Sorenson

Research output: Contribution to journalArticle

Abstract

The conversion of glucose to sorbitol by aldose reductase (AR) and its subsequent intracellular accumulation have been implicated in the pathogenesis of diabetic cataracts. There is also evidence linking AR activity with renal capillary basement membrane thickening in galactosemic rats, suggesting a possible role in diabetic retinopathy. In this study, we explored one feature of this issue by examining diabetic and nondiabetic eyes for immunoreactive AR. AR was immunohistochemically undetectable in the retinal pigment epithelia (RPE) and neural retinas of nondiabetic human eyes. Weak, focal staining for AR was present unilaterally in the RPE of 1 of 11 diabetic patients without pathologic ocular findings and in 43% of diabetic patients with mild ocular findings. Retinal positivity was found (unilaterally) in only 2 of 19 individuals from either of these mildly affected groups. Fifty-five percent of patients with background retinopathy demonstrated AR positivity in the RPE, and half of these expressed AR in the RPE of both eyes. Of the individuals with proliferative diabetic retinopathy, 87.5% showed bilateral staining in the RPE. Retinal positivity was present in 36% of background retinopathy and 75% of proliferative retinopathy cases, demonstrating a positive correlation between AR expression and the severity of the disorder. In weakly staining retinas, only the ganglion cell bodies, nerve fibers, and Muller cells were positive, whereas in intensely staining cases, virtually the entire retina, except for the rod outer segments, was positive. Eyes from patients who had had diabetes ≤ 6 yr were negative for AR, but those from long-term-diabetic patients (14-45 yr) manifested positivity. These data suggest that enhanced expression of AR may play a role in the development of diabetic retinopathy.

Original languageEnglish (US)
Pages (from-to)1658-1664
Number of pages7
JournalDiabetes
Volume37
Issue number12
StatePublished - 1988
Externally publishedYes

Fingerprint

Aldehyde Reductase
Retinal Pigment Epithelium
Retina
Diabetic Retinopathy
Staining and Labeling
Pigment Epithelium of Eye
Ependymoglial Cells
Rod Cell Outer Segment
Sorbitol
Nerve Fibers
Basement Membrane
Ganglia
Cataract
Kidney
Neurons
Glucose

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Vinores, S. A., Campochiaro, P. A., Williams, E. H., May, E. E., Green, W. R., & Sorenson, R. L. (1988). Aldose reductase expression in human diabetic retina and retinal pigment epithelium. Diabetes, 37(12), 1658-1664.

Aldose reductase expression in human diabetic retina and retinal pigment epithelium. / Vinores, S. A.; Campochiaro, Peter A; Williams, E. H.; May, E. E.; Green, W. R.; Sorenson, R. L.

In: Diabetes, Vol. 37, No. 12, 1988, p. 1658-1664.

Research output: Contribution to journalArticle

Vinores, SA, Campochiaro, PA, Williams, EH, May, EE, Green, WR & Sorenson, RL 1988, 'Aldose reductase expression in human diabetic retina and retinal pigment epithelium', Diabetes, vol. 37, no. 12, pp. 1658-1664.
Vinores SA, Campochiaro PA, Williams EH, May EE, Green WR, Sorenson RL. Aldose reductase expression in human diabetic retina and retinal pigment epithelium. Diabetes. 1988;37(12):1658-1664.
Vinores, S. A. ; Campochiaro, Peter A ; Williams, E. H. ; May, E. E. ; Green, W. R. ; Sorenson, R. L. / Aldose reductase expression in human diabetic retina and retinal pigment epithelium. In: Diabetes. 1988 ; Vol. 37, No. 12. pp. 1658-1664.
@article{883aff40756d4539b50ebd3985f14000,
title = "Aldose reductase expression in human diabetic retina and retinal pigment epithelium",
abstract = "The conversion of glucose to sorbitol by aldose reductase (AR) and its subsequent intracellular accumulation have been implicated in the pathogenesis of diabetic cataracts. There is also evidence linking AR activity with renal capillary basement membrane thickening in galactosemic rats, suggesting a possible role in diabetic retinopathy. In this study, we explored one feature of this issue by examining diabetic and nondiabetic eyes for immunoreactive AR. AR was immunohistochemically undetectable in the retinal pigment epithelia (RPE) and neural retinas of nondiabetic human eyes. Weak, focal staining for AR was present unilaterally in the RPE of 1 of 11 diabetic patients without pathologic ocular findings and in 43{\%} of diabetic patients with mild ocular findings. Retinal positivity was found (unilaterally) in only 2 of 19 individuals from either of these mildly affected groups. Fifty-five percent of patients with background retinopathy demonstrated AR positivity in the RPE, and half of these expressed AR in the RPE of both eyes. Of the individuals with proliferative diabetic retinopathy, 87.5{\%} showed bilateral staining in the RPE. Retinal positivity was present in 36{\%} of background retinopathy and 75{\%} of proliferative retinopathy cases, demonstrating a positive correlation between AR expression and the severity of the disorder. In weakly staining retinas, only the ganglion cell bodies, nerve fibers, and Muller cells were positive, whereas in intensely staining cases, virtually the entire retina, except for the rod outer segments, was positive. Eyes from patients who had had diabetes ≤ 6 yr were negative for AR, but those from long-term-diabetic patients (14-45 yr) manifested positivity. These data suggest that enhanced expression of AR may play a role in the development of diabetic retinopathy.",
author = "Vinores, {S. A.} and Campochiaro, {Peter A} and Williams, {E. H.} and May, {E. E.} and Green, {W. R.} and Sorenson, {R. L.}",
year = "1988",
language = "English (US)",
volume = "37",
pages = "1658--1664",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "12",

}

TY - JOUR

T1 - Aldose reductase expression in human diabetic retina and retinal pigment epithelium

AU - Vinores, S. A.

AU - Campochiaro, Peter A

AU - Williams, E. H.

AU - May, E. E.

AU - Green, W. R.

AU - Sorenson, R. L.

PY - 1988

Y1 - 1988

N2 - The conversion of glucose to sorbitol by aldose reductase (AR) and its subsequent intracellular accumulation have been implicated in the pathogenesis of diabetic cataracts. There is also evidence linking AR activity with renal capillary basement membrane thickening in galactosemic rats, suggesting a possible role in diabetic retinopathy. In this study, we explored one feature of this issue by examining diabetic and nondiabetic eyes for immunoreactive AR. AR was immunohistochemically undetectable in the retinal pigment epithelia (RPE) and neural retinas of nondiabetic human eyes. Weak, focal staining for AR was present unilaterally in the RPE of 1 of 11 diabetic patients without pathologic ocular findings and in 43% of diabetic patients with mild ocular findings. Retinal positivity was found (unilaterally) in only 2 of 19 individuals from either of these mildly affected groups. Fifty-five percent of patients with background retinopathy demonstrated AR positivity in the RPE, and half of these expressed AR in the RPE of both eyes. Of the individuals with proliferative diabetic retinopathy, 87.5% showed bilateral staining in the RPE. Retinal positivity was present in 36% of background retinopathy and 75% of proliferative retinopathy cases, demonstrating a positive correlation between AR expression and the severity of the disorder. In weakly staining retinas, only the ganglion cell bodies, nerve fibers, and Muller cells were positive, whereas in intensely staining cases, virtually the entire retina, except for the rod outer segments, was positive. Eyes from patients who had had diabetes ≤ 6 yr were negative for AR, but those from long-term-diabetic patients (14-45 yr) manifested positivity. These data suggest that enhanced expression of AR may play a role in the development of diabetic retinopathy.

AB - The conversion of glucose to sorbitol by aldose reductase (AR) and its subsequent intracellular accumulation have been implicated in the pathogenesis of diabetic cataracts. There is also evidence linking AR activity with renal capillary basement membrane thickening in galactosemic rats, suggesting a possible role in diabetic retinopathy. In this study, we explored one feature of this issue by examining diabetic and nondiabetic eyes for immunoreactive AR. AR was immunohistochemically undetectable in the retinal pigment epithelia (RPE) and neural retinas of nondiabetic human eyes. Weak, focal staining for AR was present unilaterally in the RPE of 1 of 11 diabetic patients without pathologic ocular findings and in 43% of diabetic patients with mild ocular findings. Retinal positivity was found (unilaterally) in only 2 of 19 individuals from either of these mildly affected groups. Fifty-five percent of patients with background retinopathy demonstrated AR positivity in the RPE, and half of these expressed AR in the RPE of both eyes. Of the individuals with proliferative diabetic retinopathy, 87.5% showed bilateral staining in the RPE. Retinal positivity was present in 36% of background retinopathy and 75% of proliferative retinopathy cases, demonstrating a positive correlation between AR expression and the severity of the disorder. In weakly staining retinas, only the ganglion cell bodies, nerve fibers, and Muller cells were positive, whereas in intensely staining cases, virtually the entire retina, except for the rod outer segments, was positive. Eyes from patients who had had diabetes ≤ 6 yr were negative for AR, but those from long-term-diabetic patients (14-45 yr) manifested positivity. These data suggest that enhanced expression of AR may play a role in the development of diabetic retinopathy.

UR - http://www.scopus.com/inward/record.url?scp=0024211152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024211152&partnerID=8YFLogxK

M3 - Article

VL - 37

SP - 1658

EP - 1664

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 12

ER -